Zobrazeno 1 - 10
of 1 281
pro vyhledávání: '"Veronese, Ml"'
Autor:
Vogel A; Hannover Medical School, Hannover, Germany; Toronto General Hospital, Toronto, Canada; Princess Margaret Cancer Centre, Toronto, Canada. Electronic address: vogela@me.com., Zhen H; Incyte Corporation, Wilmington, USA., Veronese ML; Incyte International Biosciences Sàrl, Morges, Switzerland., Abou-Alfa GK; Memorial Sloan Kettering Cancer Center, New York, USA; Weill Medical College at Cornell University, New York, USA; Trinity College Dublin School of Medicine, Dublin, Ireland.
Publikováno v:
ESMO open [ESMO Open] 2024 Nov; Vol. 9 (11), pp. 103937. Date of Electronic Publication: 2024 Oct 17.
Autor:
Rodón J; The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jrodon@mdanderson.org., Damian S; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Furqan M; University of Iowa, Iowa City, IA, USA., García-Donas J; Centro Integral Oncologico Clara Campal, Madrid, Spain., Imai H; Tohoku University Hospital, Sendai-Shi, Japan., Italiano A; Institut Bergonié, Bordeaux, France.; Faculty of Medicine, University of Bordeaux, Bordeaux, France., Spanggaard I; Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark., Ueno M; Kanagawa Cancer Center, Yokohama, Japan., Yokota T; Shizuoka Cancer Center, Shizuoka, Japan., Veronese ML; Incyte International Biosciences Sàrl, Morges, Switzerland., Oliveira N; Incyte International Biosciences Sàrl, Morges, Switzerland., Li X; Incyte Corporation, Wilmington, DE, USA., Gilmartin A; Incyte Corporation, Wilmington, DE, USA., Schaffer M; Incyte Corporation, Wilmington, DE, USA., Goyal L; Mass General Cancer Center, Harvard Medical School, Boston, MA, USA. lgoyal@stanford.edu.; Stanford Cancer Center, Stanford School of Medicine, Stanford, CA, USA. lgoyal@stanford.edu.
Publikováno v:
Nature medicine [Nat Med] 2024 Aug; Vol. 30 (8), pp. 2377.
Autor:
Saleh M; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, USA; Department of Hematology and Oncology, Aga Khan University, Nairobi, Kenya. Electronic address: mansoor.saleh@aku.edu., Barve M; Mary Crowley Cancer Research Center, Dallas., Subbiah V; Sarah Cannon Research Institute, Nashville., Papadopoulos KP; START San Antonio, San Antonio., Morgensztern D; Division of Oncology, Washington University School of Medicine, St. Louis., Mettu NB; Division of Medical Oncology, Duke University Medical Center, Durham., Roychowdhury S; The Ohio State University Comprehensive Cancer Center, Columbus, USA., Spanggaard I; Department of Oncology, Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark., Veronese ML; Incyte International Biosciences Sàrl, Morges, Switzerland., Tian C; Incyte Corporation, Wilmington., Silverman IM; Incyte Corporation, Wilmington., Gutierrez M; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, USA.
Publikováno v:
ESMO open [ESMO Open] 2024 Jul; Vol. 9 (7), pp. 103625. Date of Electronic Publication: 2024 Jul 09.
Autor:
Rodón J; The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jrodon@mdanderson.org., Damian S; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Furqan M; University of Iowa, Iowa City, IA, USA., García-Donas J; Centro Integral Oncologico Clara Campal, Madrid, Spain., Imai H; Tohoku University Hospital, Sendai-Shi, Japan., Italiano A; Institut Bergonié, Bordeaux, France.; Faculty of Medicine, University of Bordeaux, Bordeaux, France., Spanggaard I; Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark., Ueno M; Kanagawa Cancer Center, Yokohama, Japan., Yokota T; Shizuoka Cancer Center, Shizuoka, Japan., Veronese ML; Incyte International Biosciences Sàrl, Morges, Switzerland., Oliveira N; Incyte International Biosciences Sàrl, Morges, Switzerland., Li X; Incyte Corporation, Wilmington, DE, USA., Gilmartin A; Incyte Corporation, Wilmington, DE, USA., Schaffer M; Incyte Corporation, Wilmington, DE, USA., Goyal L; Mass General Cancer Center, Harvard Medical School, Boston, MA, USA. lgoyal@stanford.edu.; Stanford Cancer Center, Stanford School of Medicine, Stanford, CA, USA. lgoyal@stanford.edu.
Publikováno v:
Nature medicine [Nat Med] 2024 Jun; Vol. 30 (6), pp. 1645-1654. Date of Electronic Publication: 2024 May 06.
Autor:
Vogel A; Hannover Medical School, Hannover, Germany; Toronto General Hospital, Toronto; Princess Margaret Cancer Centre, Toronto, Canada. Electronic address: vogela@me.com., Sahai V; University of Michigan, Ann Arbor, USA., Hollebecque A; Gustave Roussy Cancer Center, Paris, France., Vaccaro GM; Providence Cancer Center, Portland, USA., Melisi D; Università degli studi di Verona, Verona, Italy., Al Rajabi RM; University of Kansas Medical Center, Kansas City., Paulson AS; Baylor University Medical Center, Dallas., Borad MJ; Mayo Clinic Cancer Center, Phoenix., Gallinson D; Morristown Memorial Hospital, Morristown., Murphy AG; Johns Hopkins University School of Medicine, Baltimore, USA., Oh DY; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Integrated Major in Innovative Medical Science, Seoul National University Graduate School, Seoul, Republic of Korea., Dotan E; Fox Chase Cancer Center, Philadelphia., Catenacci DV; University of Chicago Medicine, Chicago, USA., Van Cutsem E; University Hospitals Gasthuisberg, Leuven & University of Leuven, Leuven, Belgium., Lihou CF; Incyte Corporation, Wilmington, USA., Zhen H; Incyte Corporation, Wilmington, USA., Veronese ML; Incyte International Biosciences Sàrl, Morges, Switzerland., Abou-Alfa GK; Memorial Sloan Kettering Cancer Center, New York; Weill Medical College at Cornell University, New York, USA; Trinity College Dublin School of Medicine, Dublin, Ireland.
Publikováno v:
ESMO open [ESMO Open] 2024 Jun; Vol. 9 (6), pp. 103488. Date of Electronic Publication: 2024 Jun 04.
Autor:
Necchi A; Vita-Salute San Raffaele University, Department of Medical Oncology, IRCCS San Raffaele Hospital, Milan, Italy. Electronic address: Necchi.andrea@hsr.it., Pouessel D; Institut Claudius Regaud-IUCT Oncopole, Toulouse, France., Leibowitz R; Chaim Sheba Medical Center, Ramat Gan; Shamir Medical Center, Zerifin, Israel., Gupta S; Huntsman Cancer Institute, Salt Lake City, USA., Fléchon A; Centre Léon Bérard, Lyon, France., García-Donas J; Centro Integral Oncologico Clara Campal, Madrid, Spain., Bilen MA; Winship Cancer Institute of Emory University, Atlanta, USA., Debruyne PR; Kortrijk Cancer Centre, General Hospital Groeninge, Kortrijk, Belgium; Medical Technology Research Centre (MTRC), School of Life Sciences, Anglia Ruskin University, Cambridge; School of Nursing and Midwifery, University of Plymouth, Plymouth, UK., Milowsky MI; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill., Friedlander T; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, USA., Maio M; University of Siena and Center for Immuno-Oncology, Department of Oncology, University Hospital, Siena, Italy., Gilmartin A; Incyte Corporation, Wilmington, USA., Li X; Incyte Corporation, Wilmington, USA., Veronese ML; Incyte International Biosciences Sàrl, Morges, Switzerland., Loriot Y; Gustave Roussy, DITEP, Université Paris-Saclay, INSERM 981, Villejuif, France. Electronic address: Yohann.loriot@gustaveroussy.fr.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Feb; Vol. 35 (2), pp. 200-210. Date of Electronic Publication: 2023 Nov 11.
Autor:
Le Tourneau C; Department of Drug Development and Innovation (D3i), Institut Curie, INSERM U900 Research Unit, Paris-Saclay University, Paris, France., André F; Institut Gustave Roussy, Paris, France., Helland Å; Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Mileshkin L; Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia., Minnaard W; Missie Tumor Onbekend, Amsterdam, Netherlands., Schiel A; Norwegian Medicines Agency, Oslo, Norway., Taskén K; Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Thomas DM; Garvan Institute of Medical Research, Darlinghurst, Australia., Veronese ML; Incyte International Biosciences Sàrl, Morges, Switzerland., Durán-Pacheco G; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Leyens L; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Rufibach K; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Thomas M; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Krämer A; Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ) and Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany. Electronic address: a.kraemer@Dkfz-Heidelberg.de.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2023 Nov; Vol. 194, pp. 113278. Date of Electronic Publication: 2023 Aug 04.
Autor:
Baffa, Raffaele, Veronese, Ml, Santoro, R, Mandes, B, Palazzo, Jp, Rugge, Massimo, Santoro, E, Croce, Cm, Huebner, K.
Publikováno v:
Cancer research. 58(20)
Loss of heterozygosity involving the short arm of chromosome 3 has been reported in gastric and other human tumors. We have cloned and mapped a candidate tumor suppressor gene, FHIT (fragile histidine triad), to this chromosomal region (3p14.2). To i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::3a9281441021b42b1f84a1a884c4f7bf
https://pubmed.ncbi.nlm.nih.gov/9788626
https://pubmed.ncbi.nlm.nih.gov/9788626
Autor:
Martinez, R, Venturelli, D, Perrotti, D, Veronese, Ml, Kastury, K, Druck, T, Huebner, K, Calabretta, Bruno
Publikováno v:
Cancer research. 57(6)
DR-nm23 cDNA was cloned recently by differential screening of a cDNA library derived from chronic myelogenous leukemia-blast crisis primary cells. It is highly homologous to the putative metastasis suppressor nm23-H1 gene and the closely related nm23
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::7beada4fe29fcb5fd424acc2fdd7f48d
https://pubmed.ncbi.nlm.nih.gov/9067290
https://pubmed.ncbi.nlm.nih.gov/9067290
Autor:
Sozzi, G, Sard, L, DE GREGORIO, L, Marchetti, A, Musso, K, Buttitta, F, Tornielli, S, Pellegrini, Silvia, Veronese, Ml, Manenti, G, Incarbone, M, Chella, A, Angeletti, Ca, Pastorino, U, Huebner, K, Bevilacqua, Generoso, Pilotti, S, Croce, Cm, Pierotti, M. A.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3728::993964933f9df4a08a95aa4e1239d0fc
http://hdl.handle.net/11568/204287
http://hdl.handle.net/11568/204287
